 If the flow after 2 years are fully comparable clinical outcomes, minimal migration as measured by RSA and final preservation of the bone around the implant, then the use of the implant extends to several clinics at home and abroad, as per the recommendations of the Danish Orthopaedic Association reference program for hip replacement surgery. 